Morgan Stanley Maintains Overweight on 2seventy bio, Lowers Price Target to $28

Morgan Stanley analyst Matthew Harrison maintains 2seventy bio (NASDAQ:TSVT) with a Overweight and lowers the price target from $29 to $28.

Morgan Stanley analyst Matthew Harrison maintains 2seventy bio (NASDAQ:TSVT) with a Overweight and lowers the price target from $29 to $28.

Total
0
Shares
Related Posts